Encompass Health reaffirms full-year 2025 guidance ahead of investor meetings

Encompass Health Corp

Net operating revenue expected $5,905M to $5,955M.
Adjusted EBITDA guidance range of $1,235M to $1,255M.
Adjusted EPS from continuing ops attributed to Encompass Health: $5.22 to $5.37.
Management to meet investors December 2–3, 2025; guidance unchanged from Oct 29, 2025.

item 7.01

Encompass Health Corp filing history →

Source: SEC EDGAR

accession 0000785161-25-000118

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.